General Information
Drug ID
DR00443
Drug Name
Gliclazide
Synonyms
1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea; 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; Diaikron; Diamicron; Diamicron (TN); Dianorm (TN); Gliclazida; Gliclazida [INN-Spanish]; Gliclazide (JAN/INN); Gliclazide [BAN:INN:DCF:JAN]; Gliclazidum; Gliclazidum [INN-Latin]; Gliklazid; Glimicron; Glimicron (TN); Glubitor-OD (TN); Glyclazide; N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide; N-[(hexahydrocyclopenta[c]pyrrol-2(1H)-ylamino)carbonyl]-4-methylbenzenesulfonamide; Nordialex; S 1702; S 852; S-1702; S-852; SE 1702
Drug Type
Small molecular drug
Therapeutic Class
Hypoglycemic Agents
Structure
3D MOL 2D MOL
Formula
C15H21N3O3S
Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
InChI
InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)
InChIKey
BOVGTQGAOIONJV-UHFFFAOYSA-N
CAS Number
CAS 21187-98-4
Pharmaceutical Properties Molecular Weight 323.4 Topological Polar Surface Area 86.9
Heavy Atom Count 22 Rotatable Bond Count 3
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 4
XLogP
1.5
PubChem CID
3475
PubChem SID
10321809 ,11342141 ,11362324 ,11364372 ,11366934 ,11369496 ,11372903 ,11374235 ,11377658 ,11466586 ,11467706 ,11486292 ,11487726 ,11491677 ,11492413 ,11495292 ,11533945 ,14826273 ,24895090 ,26612635 ,26612723 ,26748918 ,26748919 ,26748920 ,29222608 ,3206372 ,47656599 ,47730748 ,48179242 ,48179243 ,48328563 ,48403959 ,48416054 ,49646130 ,49698833 ,50061218 ,50086570 ,50107481 ,50107482 ,50107483 ,5035155 ,50880518 ,57321824 ,7848662 ,7979407 ,81040947 ,81066070 ,81093129 ,8152209 ,85280584
ChEBI ID
ChEBI:31654
TTD Drug ID
D0M2MR

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.